The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 7,833 | 116,581 | SH | SOLE | 116,581 | 0 | 0 | ||
ACHILLION PHARMACEUTICALS | COM | 00448Q201 | 4,255 | 480,300 | SH | SOLE | 480,300 | 0 | 0 | ||
ACTINIUM PHARMACEUTICALS INC | COM | 00507W107 | 239 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 2,768 | 156,842 | SH | SOLE | 156,842 | 0 | 0 | ||
AFFIMED THERAPEUTICS BV | COM | N01045108 | 390 | 28,950 | SH | SOLE | 28,950 | 0 | 0 | ||
ANTARES PHARMA INC | COM | 036642106 | 94 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 2,411 | 157,192 | SH | SOLE | 157,192 | 0 | 0 | ||
APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 359 | 70,396 | SH | SOLE | 70,396 | 0 | 0 | ||
ARCA BIOPHARMA INC | COM NEW | 00211Y209 | 653 | 567,859 | SH | SOLE | 567,859 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM | 040047102 | 877 | 189,000 | SH | SOLE | 189,000 | 0 | 0 | ||
ASCENDIS PHARMA | ADR ADDED | 04351P101 | 1,654 | 93,541 | SH | SOLE | 93,541 | 0 | 0 | ||
ATRICURE INC | COM | 04963C209 | 13,518 | 548,611 | SH | SOLE | 548,611 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 3,309 | 221,656 | SH | SOLE | 221,656 | 0 | 0 | ||
BIOTELEMETRY INC | COM | 090672106 | 2,222 | 235,645 | SH | SOLE | 235,645 | 0 | 0 | ||
BIOTIE THERAPIES | ADR | 09074D103 | 200 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 1,010 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
CALADRIUS BIOSCIENCES INC | COM | 128058104 | 166 | 88,900 | SH | SOLE | 88,900 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 1,543 | 126,956 | SH | SOLE | 126,956 | 0 | 0 | ||
CARDICA INC | COM | 14141R101 | 742 | 1,486,004 | SH | SOLE | 1,486,004 | 0 | 0 | ||
CAREDX INC | COM | 14167L103 | 947 | 145,627 | SH | SOLE | 145,627 | 0 | 0 | ||
CAS MEDICAL SYSTEMS INC | COM PAR $0.004 | 124769209 | 113 | 88,522 | SH | SOLE | 88,522 | 0 | 0 | ||
CEL SCI CORP | COM PAR $0.01 | 150837508 | 209 | 316,500 | SH | SOLE | 316,500 | 0 | 0 | ||
CELYAD | ADR | 151205200 | 1,561 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
CHECK CAP LTD | SHS ADDED | M2361E112 | 385 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
CHECK CAP LTD | *W EXP 02/28/202 ADDED | M2361E120 | 96 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
CHEMBIO DIAGNOSTICS INC | COM NEW | 163572209 | 129 | 26,287 | SH | SOLE | 26,287 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 2,029 | 23,090 | SH | SOLE | 23,090 | 0 | 0 | ||
COGENTIX MEDICAL INC | COM | 19243A104 | 572 | 353,181 | SH | SOLE | 353,181 | 0 | 0 | ||
CORBUS PHARMACEUTICALS HLDGS | COM | 21833P103 | 113 | 36,590 | SH | SOLE | 36,590 | 0 | 0 | ||
CYNAPSUS THERAPEUTICS INC | COM | 23257Y156 | 559 | 33,995 | SH | SOLE | 33,995 | 0 | 0 | ||
CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 915 | 44,824 | SH | SOLE | 44,824 | 0 | 0 | ||
CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 815 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
CYTRX CORP | COM PAR $.001 | 232828509 | 1,119 | 300,813 | SH | SOLE | 300,813 | 0 | 0 | ||
DERMA SCIENCES INC | COM PAR $.01 | 249827502 | 2,677 | 373,918 | SH | SOLE | 373,918 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 996 | 56,736 | SH | SOLE | 56,736 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 1,211 | 86,800 | SH | SOLE | 86,800 | 0 | 0 | ||
DISCOVERY LABORATORIES INC | COM NEW | 254668403 | 3,261 | 4,794,874 | SH | SOLE | 4,794,874 | 0 | 0 | ||
ENCISION INC | COM | 29254Q104 | 584 | 1,062,500 | SH | SOLE | 1,062,500 | 0 | 0 | ||
ESSA PHARMA INC | COM | 29668H104 | 2,626 | 231,200 | SH | SOLE | 231,200 | 0 | 0 | ||
EXACTECH INC | COM | 30064E109 | 659 | 31,636 | SH | SOLE | 31,636 | 0 | 0 | ||
GENVEC INC | COM NEW | 37246C307 | 204 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 3,285 | 106,018 | SH | SOLE | 106,018 | 0 | 0 | ||
INSULET CORP | NOTE 2.000% 6/1 | 45784PAD3 | 2,338 | 2,407,000 | PRN | SOLE | 2,407,000 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 483 | 2,000 | SH | SOLE | 2,000 | 0 | 0 | ||
IRONWOOD PHARMA | NOTE 2.25% 15-Jun-2022 144A SR UNSECURED CONV | 46333XAC2 | 396 | 400,000 | PRN | SOLE | 400,000 | 0 | 0 | ||
JOHNSON AND JOHNSON | COM | 478160104 | 916 | 9,400 | SH | SOLE | 9,400 | 0 | 0 | ||
LIPOCINE INC | COM NEW | 53630X104 | 729 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
LOXO ONCOLOGY INC | COM | 548862101 | 221 | 12,245 | SH | SOLE | 12,245 | 0 | 0 | ||
LUMENIS LTD | SHS CL B | M6778Q121 | 426 | 31,072 | SH | SOLE | 31,072 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM | 56854Q101 | 259 | 22,319 | SH | SOLE | 22,319 | 0 | 0 | ||
MASIMO CORPORATION | COM | 574795100 | 1,782 | 46,010 | SH | SOLE | 46,010 | 0 | 0 | ||
NEOTHETICS INC | COM | 64066G101 | 1,658 | 184,187 | SH | SOLE | 184,187 | 0 | 0 | ||
NIVALIS THERAPEUTICS INC | COM | 65481J109 | 227 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
NOVADAQ TECHNOLOGIES INC | COM | 66987G102 | 1,233 | 101,841 | SH | SOLE | 101,841 | 0 | 0 | ||
NUVASIVE INC | NOTE 2.750% 7/0 | 670704AC9 | 968 | 760,000 | PRN | SOLE | 760,000 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 5,236 | 366,554 | SH | SOLE | 366,554 | 0 | 0 | ||
ONCOTHYREON INC | COM | 682324108 | 135 | 36,180 | SH | SOLE | 36,180 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 2,563 | 111,466 | SH | SOLE | 111,466 | 0 | 0 | ||
PIERIS PHARMACEUTICALS INC | COM | 720795103 | 344 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | COM | 74365A101 | 2,400 | 1,230,789 | SH | SOLE | 1,230,789 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | NOTE 4.500% 9/1 | 74365AAB7 | 3,196 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 3,562 | 1,109,740 | SH | SOLE | 1,109,740 | 0 | 0 | ||
RTI SURGICAL INC | COM | 74975N105 | 555 | 85,918 | SH | SOLE | 85,918 | 0 | 0 | ||
SCYNEXIS INC | COM | 811292101 | 1,419 | 161,382 | SH | SOLE | 161,382 | 0 | 0 | ||
SPECTRANETICS CORP | COM | 84760C107 | 916 | 39,812 | SH | SOLE | 39,812 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 1,977 | 1,372,862 | SH | SOLE | 1,372,862 | 0 | 0 | ||
SYNERGY PHARMACEUTICALS | COM | 871639308 | 2,636 | 317,563 | SH | SOLE | 317,563 | 0 | 0 | ||
SYNERON MEDICAL LTD | ORD SHS | M87245102 | 966 | 90,947 | SH | SOLE | 90,947 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM | 875372104 | 390 | 35,992 | SH | SOLE | 35,992 | 0 | 0 | ||
TARGACEPT INC | COM | 87611R306 | 1,294 | 463,914 | SH | SOLE | 463,914 | 0 | 0 | ||
TRANSITION THERAPEUTICS INC | COM NEW | 893716209 | 124 | 59,222 | SH | SOLE | 59,222 | 0 | 0 | ||
UNIQURE B.V. | NV SHS | N90064101 | 1,080 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
VENAXIS INC | COM | 92262A107 | 295 | 658,000 | SH | SOLE | 658,000 | 0 | 0 | ||
XENOPORT INC | COM | 98411C100 | 3,255 | 531,032 | SH | SOLE | 531,032 | 0 | 0 | ||
ZOGENIX INC | COM | 98978L204 | 1,434 | 853,700 | SH | SOLE | 853,700 | 0 | 0 | ||
ZS PHARMA INC | COM | 98979G105 | 3,515 | 67,100 | SH | SOLE | 67,100 | 0 | 0 |